These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 20595209)

  • 1. Spiral gradient endpoint susceptibility testing: a fresh look at a neglected technique.
    Pong R; Boost MV; O'Donoghue MM; Appelbaum PC
    J Antimicrob Chemother; 2010 Sep; 65(9):1959-63. PubMed ID: 20595209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The correlation between the MICs deduced from Showa disk method and the MICs determined by micro-dilution method].
    Moroizumi S; Kasitani F; Isikawa M; Iwata M; Ohno A; Yamaguchi K
    Rinsho Byori; 1994 Oct; 42(10):1062-8. PubMed ID: 7996716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
    Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
    Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates.
    Farrell DJ; Sader HS; Castanheira M; Biedenbach DJ; Rhomberg PR; Jones RN
    Int J Antimicrob Agents; 2010 Jun; 35(6):537-43. PubMed ID: 20211548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing.
    Olsson-Liljequist B; Larsson P; Walder M; Miörner H
    Scand J Infect Dis Suppl; 1997; 105():13-23. PubMed ID: 9435027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
    Blondeau JM; Suter M; Borsos S
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Alexander Project: the benefits from a decade of surveillance.
    Felmingham D; White AR; Jacobs MR; Appelbaum PC; Poupard J; Miller LA; Grüneberg RN
    J Antimicrob Chemother; 2005 Oct; 56 Suppl 2():ii3-ii21. PubMed ID: 16282278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
    Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the Spiral method to determine the MIC of various antibiotics].
    Marty N; Agueda L; Carratala V; Chabanon G
    Pathol Biol (Paris); 1994 May; 42(5):448-53. PubMed ID: 7824311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria.
    Jorgensen JH; Hindler JF
    Clin Infect Dis; 2007 Jan; 44(2):280-6. PubMed ID: 17173232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results from a German interlaboratory test to establish the broth microdilution method for the determination of the minimum inhibitory concentration of bacteria from animals].
    Wallmann J; Böttner A; Hafez HM; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Sigge C; Traeder W; Waldmann KH; Werckenthin C; Zschiesche E
    Berl Munch Tierarztl Wochenschr; 2005; 118(5-6):205-13. PubMed ID: 15918484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of culture and polymerase chain reaction methods for the detection of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis in cerebrospinal fluids and middle ear effusions].
    Jbara I; Baysallar M; Kiliç A; Yetişer S; Unay B; Açikel C; Yapar M; Doğanci L
    Mikrobiyol Bul; 2007 Oct; 41(4):495-502. PubMed ID: 18173067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for antimicrobial susceptibility testing of fastidious aerobic bacteria.
    Hindler J
    Am J Med Technol; 1983 Nov; 49(11):761-7. PubMed ID: 6418005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and reproducibility assessment of tigecycline MIC determinations by Etest.
    Bolmström A; Karlsson A; Engelhardt A; Ho P; Petersen PJ; Bradford PA; Jones CH
    J Clin Microbiol; 2007 Aug; 45(8):2474-9. PubMed ID: 17522277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antibacterial activities of S-013420, a novel bicyclolide, against respiratory tract pathogens.
    Homma T; Fujimura T; Maki H; Yamano Y; Shimada J; Kuwahara S
    J Antimicrob Chemother; 2010 Jul; 65(7):1433-40. PubMed ID: 20472695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of two commercial susceptibility test methods for determination of daptomycin MICs.
    Jorgensen JH; Crawford SA
    J Clin Microbiol; 2006 Jun; 44(6):2126-9. PubMed ID: 16757608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.